Alberta Investment Management Corp acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 135,600 shares of the medical instruments supplier's stock, valued at approximately $2,574,000. Alberta Investment Management Corp owned about 0.07% of DENTSPLY SIRONA at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the business. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth about $27,000. Kennebec Savings Bank bought a new stake in DENTSPLY SIRONA during the 3rd quarter worth approximately $35,000. MassMutual Private Wealth & Trust FSB raised its stake in shares of DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares in the last quarter. Finally, Van ECK Associates Corp purchased a new position in shares of DENTSPLY SIRONA during the third quarter valued at approximately $42,000. 95.70% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have weighed in on the company. UBS Group dropped their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research note on Tuesday, December 3rd. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a "neutral" rating and a $21.00 price target on the stock. Wells Fargo & Company began coverage on shares of DENTSPLY SIRONA in a report on Friday, February 14th. They set an "equal weight" rating and a $20.00 price target on the stock. Evercore ISI reiterated an "in-line" rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Finally, Needham & Company LLC reissued a "buy" rating and set a $25.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, February 11th. Ten research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $25.85.
Read Our Latest Analysis on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Performance
NASDAQ:XRAY traded down $0.20 during trading hours on Friday, reaching $18.75. The stock had a trading volume of 1,765,748 shares, compared to its average volume of 2,326,913. The stock has a market cap of $3.73 billion, a P/E ratio of -9.06, a price-to-earnings-growth ratio of 1.81 and a beta of 0.96. The stock has a 50 day simple moving average of $18.92 and a 200 day simple moving average of $21.71. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $34.91.
DENTSPLY SIRONA Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.41%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -30.92%.
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.